ハイパルトロフィック心筋病症:ガイドラインによる治療の実践的アプローチ

Steve R Ommen¹, Christopher Semsarian²

¹Mayo Clinic, Rochester, MN, USA.

Lancet (London, England)

|October 3, 2021

まとめ

ハイパルトロフィック心筋病は,一般的な遺伝的な心臓疾患で,管理ガイドラインを更新しました. このガイドは,医療従事者が患者のケアを改善するための最新の勧告をレビューしています.

科学分野:

心臓病科
遺伝学
内科医学

背景:

ハイパルトロフィック心筋病 (HCM) は,一般的な遺伝性心血管疾患である.
HCMは専門分野に関係なくほぼすべての医療従事者に影響します
HCMの以前の管理ガイドラインは更新されました.

研究の目的:

ハイパルトロフィック心筋病管理ガイドラインの更新を簡潔に説明する.
HCM患者のための2020年勧告の実践的なガイドを提供すること.
ハイパルトロフィック心筋病の患者の管理に医療従事者を支援する.

主な方法:

ハイパルトロフィック心筋病管理ガイドラインのレビュー.
クリニカル・プラクティスの最新勧告のまとめ
医療従事者のための実用的な応用に焦点を当てます

主要な成果:

2020年のガイドラインは,HCMに関する以前の勧告の進化を表しています.
更新された戦略は診断,リスクの階層化,治療的介入を含む.
セミナーでは,HCMの管理に関する重要な変化と実践的な検討を強調しました.

結論:

最新のガイドラインの遵守は,多動性心筋病患者の最適なアウトカムに不可欠です.
このレビューは,HCMを管理する臨床医のための実用的なリソースとして機能します.
最新の推奨事項を理解することでこの遺伝的な心臓病の患者に根拠に基づいたケアが保証されます

さらに関連する動画

06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.9K

09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.7K

関連する概念動画

01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

関連する実験動画